Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the HR gene is linked to a rare form of hair loss with limb deformities.

Certain mutations in a hair growth-related gene cause a type of genetic hair loss.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Finasteride may help reduce COVID-19 infection by altering a key gene.

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

ASLNC168501 may help restore hair growth in androgenetic alopecia by improving hair follicle stem cell function.

Mutations in the SNRPE gene cause hereditary hair loss.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Serum triglyceride levels are not linked to prostate cancer risk.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

A specific DNA pattern in Malassezia restricta may be linked to hair loss in men.

ASLNC168501 may help treat hair loss by boosting hair follicle stem cell activity.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

miR-486 may help prevent hair loss in alopecia areata.

Developing microRNA-based treatments is hard but has potential.

A genetic mutation linked to longer life and less disease was found in the Amish, and a drug is being developed to replicate these benefits.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.